Literature DB >> 8258571

An assessment of the success of meperidine and promethazine sedation in medically compromised children.

K L Haney1, A G McWhorter, N S Seale.   

Abstract

A retrospective study evaluated the success of orally administered meperidine (1.0 mg/lb) and promethazine (0.5 mg/lb) combined with N20:02, and determined predictors of success in a medically, physically and/or mentally compromised population. Behavior of 143 uncooperative patients (mean age 6.4 years) was evaluated during 282 sedations. A simplified Success Index rated outcome: 1-failure, 2-moderately successful; 3-highly successful. Variables were examined for effect on outcome of sedation: physical and/or neurologic component of medical diagnosis; previous hospital experience; medication category. Children taking medications with CNS actions were significantly less likely to have either moderately successful (p = .008) or highly successful appointments (p = .002). Children with a neurologic component to their medical diagnosis were significantly less likely to have a highly successful appointment (p = .001). Oral sedation was effective for this population (77 percent were successful) and certain characteristics of the patient's condition can predict success.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258571

Source DB:  PubMed          Journal:  ASDC J Dent Child        ISSN: 1945-1954


  3 in total

1.  Summary of the scientific literature for pain and anxiety control in dentistry.

Authors:  L C Hassett
Journal:  Anesth Prog       Date:  1994

2.  Propofol's Efficacy and Outcomes on Anxious Children's Behavior in the Course of Dental Therapy: An Interventional Trial.

Authors:  Swati Singh; Nudrat Neyaz; Aditi S Tanwar; Anand N Patil; Asim M Khan; Ateet Kakti
Journal:  J Pharm Bioallied Sci       Date:  2022-07-13

Review 3.  Anesthesia for intellectually disabled.

Authors:  Kapil Chaudhary; Preranna Bagharwal; Sonia Wadhawan
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2017 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.